Stimulation of bystander T-Cell proliferation by tumor necrosis factor produced by HIV-1-infected macrophages

Journal of Human Virology

Volumn 1, Issue 4, 1998, Pages 257-266

  Godard, Chantal M ^a   Chermann, Jean Claude ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSERM   (France)

Author keywords

Apoptosis; HIV; Macrophages; T lymphocytes; T cell activation

Indexed keywords

CD4 ANTIGEN; FAS ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL DIVISION; CELL LINE; COCULTURE; COMPARATIVE STUDY; CYTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; METABOLISM; METHODOLOGY; PHYSIOLOGY; T LYMPHOCYTE; TIME; VIROLOGY;

ANTIGENS, CD4; ANTIGENS, CD95; APOPTOSIS; CELL DIVISION; CELL LINE; COCULTURE TECHNIQUES; HIV-1; HUMANS; MACROPHAGES; T-LYMPHOCYTES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032057029     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Gendelman HE, Orenstein JM, Baca LM, et al. The macrophage in the persistence and the pathogenesis of HIV infection. AIDS 1989;3:475-495.
2. Poli G, Fauci AS. Cytokine modulation of HIV expression. Semin Immunol 1993;5:165-173.
3. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature (Lond.) 1996;384:529-534.
4. Lähdevirta J, Maury CPJ, Teppo AM, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988;85:289-291.
5. Roux-Lombard P, Modoux C, Cruchaud A, Dayer JM. Purified blood monocytes from HIV-1-infected patients produce high levels of TNF-alpha and IL-1. Clin Immunol Immunopathol 1989;50:374-384.
6. Le Naour R, Raoul H, Mabondzo A, Henin Y, Bousseau A, Dormont D. Treatment of human monocyte-derived macrophages with a TNFα synthesis inhibitor prior to HIV1 infection: consequences on cytokine production and viral replication. Res Virol 1994;145:199-207.
7. Fiers W. Tumor necrosis factor: characterization at the molecular, cellular and in vivo level. FEBS Lett 1991;285: 199-212.
8. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992;10:411-452.
9. Old LJ. Tumor necrosis factor (TNF). Science 1985;230: 630-632.
10. Scheurich P, Thoma B, Ücer U, Pfizenmaier K. Immuno-regulatory activity of recombinant human tumor necrosis factor (TNF)-α: induction of TNF receptors on human T cells and TNF-α mediated enhancement of T cell responses. J Immunol 1987;138:1786-1790.
11. Kriegler M, Perez C, De Fay K, Albert I, Lu SD. A novel form of TNF/Cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 1988;53:45-53.
12. Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 1997;385:729-736.
13. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992;13:151-153.
14. Gehr G, Gentz R, Brockhaus M, Loetscher H, Lesslauer W. Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. J Immunol 1992;149:911-917.
15. Ware CF, Crowe PD, Vanarsdale TL, et al. Tumor necrosis factor (TNF) receptor expression in T lymphocytes: differential regulation of the type I TNF receptor during activation of resting and effector T cells. J Immunol 1991; 147:4229-4238.
16. + T cells induced after contact with HIV1-infected or non-infected macrophages. Res Virol 1997; 148:383-396.
17. Chermann JC. HIV-associated diseases: acute and regressive encephalopathy in a seropositive man. Res Virol 1990;141:137-141.
18. Badley AD, McElhinny JA, Leibson PJ, Lynch DH, Alderson MR, Paya CV. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol 1996;70:199-206.
19. Zheng LX, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995;377:348-351.
20. Sarin A, Conan-Cibotti M, Henkart PA. Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J Immunol 1995;155:3716-3718.
21. + T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med 1997;185:55-64.
22. Ranges GE, Bombara MP, Aiyer RA, Rice GG, Palladino MA Jr. Tumor necrosis factor-α as a proliferative signal for an IL-2-dependent T cell line: strict species specificity of action. J Immunol 1989;142:1203-1208.
23. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA, Goeddel DV. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci U S A 1991;88:9292-9296.
24. Tartaglia LA, Goeddel DV, Reynolds C, et al. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J Immunol 1993; 151:4637-4641.
25. Shalaby MR, Espevik T, Rice GC, et al. The involvement of human tumor necrosis factors-α and -β in the mixed lymphocyte reaction. J Immunol 1988;141:499-503.
26. Schall TJ, Lewis M, Koller KJ, et al. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 1990;61:361-370.
27. Kohno T, Brewer MT, Baker SL, et al. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci U S A 1990;87:8331-8335.
28. Schmidtmayerova H, Bolmont C, Baghdiguian S, Hirsch I, Chermann JC. Distinct pattern of infection and replication of HIV-1 strains in blood-derived macrophages. Virology 1992;190:124-133.
29. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
30. Vermes I, Haanen C, Steffens-Nakken H, Reuteling-sperger C. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Method 1995;184:39-51.
31. Schmid I, Krall WJ, Uittenbogaart CH, Braun J, Giorgi JV. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 1992;13:204-208.
32. Ren Y, Savill J. Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis. J Immunol 1995;154:2366-2374.
33. Matthews N, Neale ML. Cytotoxicity assays for tumour necrosis factor and lymphotoxin. In Clemens MJ, Morris AG, Gearing AJH, eds. Lymphokines and interferons: a practical approach. Oxford: IRL Press at Oxford University Press, 1987:221-225.
34. Tartaglia LA, Pennica D, Goeddel DV. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 1993;268:18542-18548.
35. Lazdins JK, Grell M, Walker MR, Woods-Cook K, Scheurich P, Pfizenmaier K. Membrane tumor necrosis factor (TNF) induced cooperative signaling of TNFR60 and TNFR80 favors induction of cell death rather than virus production in HIV-infected T cells. J Exp Med 1997;185: 81-90.
36. Vandenabeele P, Declercq W, Beyaert R, Fiers W. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 1995;5:392-399.
37. Grell M, Douni E, Wajant H, et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995;83:793-802.
38. Willie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984;142:62-77.
39. Owen-Schaub LB, Yonehara S, Crump WL III, Grimm EA. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 1992;140:197-205.
40. Klas C, Debatin KM, Jonker RR, Krammer PH. Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 1993;5:625-630.
41. Cannistra SA, Rambaldi A, Spriggs DR, Herrmann F, Kufe D, Griffin JD. Human granulocyte-macrophage colony-stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes. J Clin Invest 1987;79:1720-1728.
42. Kayagaki N, Kawasaki A, Ebata T, et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995;182:1777-1783.
43. Nagata S. Apoptosis by death factor. Cell 1997;88:355-365.
44. Von Sydow M, Sönnerborg A, Gaines H, Strannegård O. Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res Human Retroviruses 1991;7:375-380.
45. Aukrust P, Liabakk NB, Müller F, Espevik T, Froland SS. Activation of tumor necrosis factor-α system in HIV-1 infection: association with markers of immune activation. Infection 1995;23:9-15.
46. Matsuyama T, Kobayashi N, Yamamoto N. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 1991;5:1405-1417.